Onyx Biotech closed a funding round (amount undisclosed) in May 2026. The company is based in Vaterstetten, Germany. Investors in the round: Freiraum Ventures, Life Science Valley Growth Fund. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
